Abstract:
OBJECTIVE:To evaluate the efficacy of ubrogepant on patient-reported functional disability, satisfaction with study medication, and global impression of change. BACKGROUND:Ubrogepant is a small-molecule, oral calcitonin gene-related peptide receptor antagonist indicated for the acute treatment of migraine. In 2 phase 3 trials (ACHIEVE I and II), ubrogepant demonstrated efficacy vs placebo on the 2 co-primary endpoints of headache pain freedom and absence of the most bothersome migraine-associated symptom at 2 hours post dose for the 50 and 100 mg doses. Patient-reported outcomes, such as functional disability, satisfaction, and patient global impression of change, can provide additional evidence of the efficacy of an acute treatment for migraine on clinically meaningful and patient-relevant outcomes. METHODS:ACHIEVE I and ACHIEVE II were multicenter, randomized, double-blind, placebo-controlled, parallel-group, single-attack trials in adults (18-75 years) with migraine. In ACHIEVE I, participants were randomized 1:1:1 to placebo or ubrogepant 50 or 100 mg; in ACHIEVE II, participants were randomized 1:1:1 to placebo or ubrogepant 25 or 50 mg to treat a migraine attack with moderate or severe headache pain. Participants rated ability to perform daily activities on the Functional Disability Scale, before dosing and at 1, 2, 4, and 8 hours after the initial dose; satisfaction with study medication at 2 and 24 hours; and impression of overall change in migraine on the Patient Global Impression of Change scale at 2 hours. In prespecified analyses for each trial, each outcome was compared between each ubrogepant dose group and the relevant placebo group. Data were pooled from the ubrogepant 50 mg and placebo groups of the 2 trials in a post hoc analysis. RESULTS:In ACHIEVE I, 559 participants were randomized to placebo, 556 to ubrogepant 50 mg, and 557 to ubrogepant 100 mg; in ACHIEVE II, 563 were randomized to placebo, 561 to ubrogepant 25 mg, and 562 to ubrogepant 50 mg. At 2 hours post dose, significantly higher proportions of ubrogepant-treated participants vs placebo-treated participants reported being able to function normally (ACHIEVE I: ubrogepant 50 mg, 40.6% [171/421], P = .0012 vs placebo; ubrogepant 100 mg, 42.9% [192/448], P < .0001 vs placebo; placebo, 29.8% [136/456]; ACHIEVE II: ubrogepant 25 mg, 42.6% [185/434], P = .0015 vs placebo; ubrogepant 50 mg, 40.5% [188/464], P = .0118 vs placebo; placebo, 34.2% [156/456]; pooled 50 mg, 40.6% [359/885], vs pooled placebo, 32.0% [292/912]; P < .0001), were satisfied/extremely satisfied with study medication (ACHIEVE I: 50 mg, 36.3% [147/405], P < .0001 vs placebo; 100 mg, 35.8% [149/416], P = .0002 vs placebo; placebo, 24.1% [104/432]; ACHIEVE II: 25 mg, 35.1% [141/402], P = .0018 vs placebo; 50 mg, 37.8% [163/431], P < .0001 vs placebo; placebo, 24.8% [106/427]; pooled ubrogepant 50 mg, 37.1% [310/836], vs pooled placebo, 24.5% [210/859]; P < .0001), and indicated that their migraine was much/very much better on the Patient Global Impression of Change scale (ACHIEVE I: 50 mg, 34.4% [103/299], P = .0006 vs placebo; 100 mg, 34.3% [102/297], P = .0009 vs placebo; placebo, 22.0% [69/313]; ACHIEVE II: 25 mg, 34.1% [124/364], P < .0001 vs placebo; 50 mg, 33.4% [131/392], P = .0002 vs placebo; placebo, 20.7% [78/376]; pooled 50 mg, 33.9% [234/691], vs pooled placebo, 21.3% [147/689]; P < .0001). CONCLUSIONS:A significantly higher proportion of participants treated with ubrogepant were able to function normally, were satisfied with the study medication, and reported clinically meaningful improvement compared with those receiving placebo. The results reinforce the potential benefits of ubrogepant on patient-centered outcomes in the acute treatment of migraine.
journal_name
Headachejournal_title
Headacheauthors
Dodick DW,Lipton RB,Ailani J,Halker Singh RB,Shewale AR,Zhao S,Trugman JM,Yu SY,Viswanathan HNdoi
10.1111/head.13766subject
Has Abstractpub_date
2020-04-01 00:00:00pages
686-700issue
4eissn
0017-8748issn
1526-4610journal_volume
60pub_type
杂志文章相关文献
HEADACHE文献大全abstract:OBJECTIVE:The aim of this study was to evaluate the prevalence, demographic, clinical features, and possible risk factors for hemodialysis headache (HDH). BACKGROUND:HDH has been recognized for many years, but the pathophysiology of this condition is not known. High arterial blood pressure, decreased serum osmolality,...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2006.00295.x
更新日期:2006-01-01 00:00:00
abstract:OBJECTIVE:To understand treatment preferences of people with migraine and the relative importance of improvements in efficacy and avoiding adverse events (AEs), such as cognition problems or weight gain. BACKGROUND:Current preventive migraine medicines are associated with poor adherence and tolerability. There is an u...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13498
更新日期:2019-05-01 00:00:00
abstract:BACKGROUND:Though triptans are considered the standard of acute therapy for migraine attacks with headache-related disability, they are used by the minority of potentially eligible persons. Understanding the socio-demographic and headache features that predict triptan use may help to clarify barriers to optimal treatme...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2011.02032.x
更新日期:2012-02-01 00:00:00
abstract::We report the case of a man with episodic cluster headache who suffered from severe obstructive sleep apnea (OSA) as well as periodic limb movements during sleep (PLMS). His attacks of headache occurred primarily during sleep being timely to REM sleep as 90 to 120 minutes interval. OSAs were more frequent and prolonge...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2005.t01-3-05013.x
更新日期:2005-01-01 00:00:00
abstract::Aspartame, a popular dietetic sweetener, may provoke headache in some susceptible individuals. Herein, we describe three cases of young women with migraine who reported their headaches could be provoked by chewing sugarless gum containing aspartame. ...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.1997.3710665.x
更新日期:1997-11-01 00:00:00
abstract:BACKGROUND:It has been suggested that homocysteine (Hcy) and the 5'-10'-methylenetetrahydrofolate reductase (MTHFR) C677T variant are implicated in the pathogenesis of migraine. Homocysteine has the potential to damage endothelium and accelerate atherosclerosis. Genetic factors such as the MTHFR C677T polymorphism, and...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2009.01484.x
更新日期:2010-01-01 00:00:00
abstract:OBJECTIVE:The objective of this study was to assess the clinical benefits of onabotulinumtoxinA (BOTOX®) treatment on the symptoms of cervical dystonia and the frequency, severity, and associated symptoms of migraine in patients with cervical dystonia and concurrent migraine. BACKGROUND:Botulinum toxin is established ...
journal_title:Headache
pub_type: 临床试验,杂志文章
doi:10.1111/j.1526-4610.2012.02164.x
更新日期:2012-09-01 00:00:00
abstract::Over the past few years, sports-related concussion has received significant media attention making it one of the most, if not highest profile neurological disorder. Thirty-one states now have passed sports concussion laws, with 14 states pending legislation. Most concussions are managed by primary care physicians, ie,...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/j.1526-4610.2012.02138.x
更新日期:2012-05-01 00:00:00
abstract:OBJECTIVE:To assess the efficacy of melatonin as a preventive therapy for hemicrania continua in a larger population of patients than has previously been studied. BACKGROUND:Hemicrania continua is defined by its sensitivity to indomethacin. Rarely can patients be fully tapered off indomethacin without headache recurre...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.12489
更新日期:2015-03-01 00:00:00
abstract::Individuals with tension-type headache report significant anger, depression, anxiety, and stressors. However, it is not clear to what extent these variables are interrelated. The objective of the present study was to explore the role of anger in headaches, and to examine its relationship to anxiety, depression, and da...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.2001.111006021.x
更新日期:2001-01-01 00:00:00
abstract:BACKGROUND:Fast relief of migraine pain, associated symptoms, and migraine-related disability are priorities in the acute treatment of migraine. Efforts to improve the pharmacokinetic profiles of acute migraine treatments with the aim of providing faster relief include the development of non-oral routes of administrati...
journal_title:Headache
pub_type: 杂志文章,随机对照试验
doi:10.1111/head.13165
更新日期:2017-11-01 00:00:00
abstract:OBJECTIVES:To examine the relationship between migraine and nonmigrainous headache and asthma, hay fever, and chronic bronchitis in a large cross-sectional population-based study. BACKGROUND:Associations between prevalence of migraine and asthma or allergy have been demonstrated in clinic-based and epidemiologic studi...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2006.00597.x
更新日期:2007-02-01 00:00:00
abstract::A 48-year-old slender woman presented with a rare case of spontaneous intracranial hypotension syndrome manifesting as patulous Eustachian tube. The patient complained of sudden onset of ear fullness and nasal voice as well as typical orthostatic headache. Patulous Eustachian tube was identified by observation of sync...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2006.00661.x
更新日期:2007-01-01 00:00:00
abstract::If you vomit with migraines, get full-blown migraines upon awakening, or want rapid relief without injections, consider a nasal spray. Options include triptans (zolmitriptan [Zomig] or sumatriptan [Imitrex]), DHE (Migranal), or an NSAID (Sprix). ...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.12045
更新日期:2013-03-01 00:00:00
abstract::This study examined the relationship between the menstrual cycle, the stress process, and migraines. Women migraineurs (N = 12) and a matched control sample (N = 12) completed a set of questionnaires assessing stress, appraisal, and coping at premenses, menses, and ovulation. In addition, migraineurs completed a month...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.1996.3609531.x
更新日期:1996-10-01 00:00:00
abstract:OBJECTIVES:To assess the prevalence and impact of migraine headaches in US Army soldiers deployed in support of Operation Iraqi Freedom. METHODS:A brigade of US Army soldiers stationed at Ft. Lewis, Washingtion was given a self-administered headache questionnaire within 10 days of return from a 1-year combat tour in I...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2008.01159.x
更新日期:2008-06-01 00:00:00
abstract:OBJECTIVE:To investigate the impact of coumarin therapy on migraine attack frequency. BACKGROUND:Sporadic case reports and clinical studies have described beneficial effects of coumarin therapy on migraine severity. DESIGN AND METHODS:A retrospective follow-up study based on a prescription database covering a populat...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.2001.01141.x
更新日期:2001-09-01 00:00:00
abstract::Minor trauma to the head or neck is occasionally followed by severe chronic headaches. We have evaluated 35 adults (27 women, 8 men) with no prior history of headaches, who developed recurrent episodic attacks typical of common or classic migraine following minor head or neck injuries ("post-traumatic migraine"-PTM). ...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.1991.hed3107451.x
更新日期:1991-07-01 00:00:00
abstract:OBJECTIVE:To evaluate the sensitivity of the new International Classification of Headache Disorders-2nd edition (ICHD-II) criteria in the diagnosis of childhood migraine and to propose specific criteria for the diagnosis of childhood migraine. BACKGROUND:In 2004, ICHD-II was adopted by the International Headache Socie...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2005.00260.x
更新日期:2005-11-01 00:00:00
abstract::A case is reported in which a patient with sexual and orgasmic headaches was treated successfully with a calcium channel blocker, diltiazem. To the best of our knowledge, this is the first case of successful treatment of sexual headaches with calcium channel blockers reported in the English medical literature. The lit...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/j.1526-4610.1991.hed3103141.x
更新日期:1991-03-01 00:00:00
abstract::A 33-year-old woman developed persistent postural headache following epidural anesthesia (L2-L3 level). Iohexol myelography (L5-S1 puncture) demonstrated no epidural extravasation of contrast material (Figure A), but subsequent computed tomography (CT) axial images (B, C) revealed leakage of dye through the needle tra...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.2003.03114.x
更新日期:2003-06-01 00:00:00
abstract:BACKGROUND:Research imaging of brain structure and function has helped to elucidate the pathophysiology of medication overuse headache (MOH). METHODS:This is a narrative review of imaging research studies that have investigated brain structural and functional alterations associated with MOH. Studies included in this r...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/head.13037
更新日期:2017-07-01 00:00:00
abstract:BACKGROUND:Erenumab, a calcitonin gene-related peptide (CGRP) receptor monoclonal antibody, has been well tolerated with good efficacy for the preventive treatment of episodic and chronic migraine in phase 2 and phase 3 clinical trials. Limited post-market observations are available to validate these findings in a real...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13951
更新日期:2020-10-01 00:00:00
abstract:OBJECTIVE:To review the scope of the problem facing individuals with migraine who are under- or uninsured. In this first of a 2-part narrative review, we will explore migraine epidemiology and the challenges that face this vulnerable population. BACKGROUND:Implementation of the Affordable Care Act has improved access ...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/head.13286
更新日期:2018-04-01 00:00:00
abstract::Hemicrania continua (HC) is a rare type of primary headache characterized by a prompt and enduring response to indomethacin. We describe a patient who suffered from cluster headache evolving into ipsilateral HC, who does not tolerate a long-term indomethacin therapy. The case was complex in terms of diagnosis, associa...
journal_title:Headache
pub_type: 信件
doi:10.1111/j.1526-4610.2008.01249.x
更新日期:2008-10-01 00:00:00
abstract:BACKGROUND:MAP0004 is a novel orally inhaled formulation of dihydroergotamine mesylate (DHE) currently in development that has been clinically observed to provide rapid ( approximately 10 minutes) therapeutic levels of DHE but with lower rates of adverse effects (dizziness, nausea, and paresthesia) compared with intrav...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2009.01510.x
更新日期:2009-11-01 00:00:00
abstract:BACKGROUND:New treatments are needed to treat chronic daily headache (CDH) and chronic cluster headache (CCH). New treatments are needed to treat this population and intravenous (IV) lidocaine is a novel treatment for CDH. OBJECTIVE:The aim of this study was to examine the use of IV lidocaine for refractory CDH patien...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2008.01281.x
更新日期:2009-02-01 00:00:00
abstract:OBJECT:To investigate the rhythmicity of migraine episodes without aura in a pediatric population. METHODS:Time of occurrence of 2517 migraine attacks in 115 children was recorded, by means of a diary, both by hourly and monthly intervals. RESULTS:A significant circadian variation, characterized by a peak in the afte...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2006.00613.x
更新日期:2006-11-01 00:00:00
abstract:OBJECTIVES:This study evaluated the long-term safety of oral almotriptan 12.5 mg for the treatment of multiple migraine episodes in adolescents over a 12-month period. Efficacy outcomes were assessed as a secondary objective. METHODS:Adolescent migraineurs aged 12-17 years were enrolled in this 12-month, open-label st...
journal_title:Headache
pub_type: 临床试验,杂志文章,多中心研究
doi:10.1111/j.1526-4610.2010.01655.x
更新日期:2010-05-01 00:00:00
abstract:BACKGROUND:It is commonly known that headaches are induced by intake of specific food, drink, and/or additive. In addition, some patients experience postprandial headache independent of ingestion of specific items. Currently, information on the pathophysiology underlying this particular type of headache is scarce. CAS...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13136
更新日期:2017-10-01 00:00:00